{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:05:22Z","timestamp":1787313922924,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111593","type":"journal-article","created":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T10:42:23Z","timestamp":1565433743000},"page":"111593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-7219","authenticated-orcid":false,"given":"Mohamed M.","family":"Elsebaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader S.","family":"Abutaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Mahgoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hagras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-7963","authenticated-orcid":false,"given":"Haroon","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-0458","authenticated-orcid":false,"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3987-3680","authenticated-orcid":false,"given":"Abdelrahman S.","family":"Mayhoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111593_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejmech.2017.08.039","article-title":"Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis","volume":"139","author":"Eid","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2018.04.049","article-title":"Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens","volume":"152","author":"ElAwamy","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib3","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acsinfecdis.8b00172","article-title":"Naphthylthiazoles: targeting multidrug-resistant and intracellular Staphylococcus aureus with biofilm disruption activity","volume":"4","author":"Hagras","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111593_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2019.04.063","article-title":"Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity","volume":"175","author":"Elsebaei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejmech.2018.03.044","article-title":"Phenylthiazoles with tert-Butyl side chain: metabolically stable with anti-biofilm activity","volume":"151","author":"Kotb","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ejmech.2017.10.048","article-title":"Biphenylthiazole antibiotics with an oxadiazole linker: an approach to improve physicochemical properties and oral bioavailability","volume":"143","author":"Hagras","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib7","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1021\/acs.jmedchem.7b00392","article-title":"Investigating the antibacterial activity of biphenylthiazoles against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)","volume":"60","author":"Hagras","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ja.2014.142","article-title":"Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci","volume":"68","author":"Mohammad","year":"2015","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2019.111593_bib9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/jm401905m","article-title":"Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus","volume":"57","author":"Mohammad","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib10","article-title":"Antibacterial characterization of novel synthetic thiazole compounds against methicillin-resistant Staphylococcus pseudintermedius","volume":"10","author":"Mohammad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111593_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejmech.2015.03.015","article-title":"Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"94","author":"Mohammad","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182821","article-title":"Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus","volume":"12","author":"Mohammad","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111593_bib13","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1021\/acs.jmedchem.6b00233","article-title":"Second-generation phenylthiazole antibiotics with enhanced pharmacokinetic properties","volume":"59","author":"Seleem","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejmech.2016.11.042","article-title":"Phenylthiazole antibiotics: a metabolism-guided approach to overcome short duration of action","volume":"126","author":"Yahia","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199710","article-title":"Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)","volume":"13","author":"AbdelKhalek","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111593_bib16","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1021\/acs.jmedchem.6b01780","article-title":"Phenylthiazole antibacterial agents targeting cell wall synthesis exhibit potent activity in\u00a0vitro and in\u00a0vivo against vancomycin-resistant enterococci","volume":"60","author":"Mohammad","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1208\/s12249-015-0360-7","article-title":"Hot-melt extrusion: from theory to application in pharmaceutical formulation","volume":"17","author":"Patil","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejmech.2019.111593_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/17425247.2016.1126246","article-title":"Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century","volume":"13","author":"Tiwari","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2019.111593_bib19","series-title":"Solid Dispersion Formulation of an Antiviral Compound","author":"Mogalian","year":"2014"},{"key":"10.1016\/j.ejmech.2019.111593_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1039\/C1MD00017A","article-title":"Molecular obesity, potency and other addictions in drug discovery","volume":"2","author":"Hann","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.111593_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111593_bib22","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/jm1013538","article-title":"Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins","volume":"54","author":"Mayhoub","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/iid3.234","article-title":"Evidence of latent molecular diversity determining the virulence of community-associated MRSA USA300 clones in mice","volume":"6","author":"Sonoda","year":"2018","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.ejmech.2019.111593_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.diagmicrobio.2017.04.016","article-title":"Continued expansion of USA300-like methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients in the United States","volume":"88","author":"Tickler","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111593_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/eri.09.127","article-title":"Diagnosis and management of community-associated MRSA infections in children","volume":"8","author":"Long","year":"2010","journal-title":"Expert Rev Anti-Infe"},{"key":"10.1016\/j.ejmech.2019.111593_bib26","article-title":"Are the physicochemical properties of antibacterial compounds really different from other drugs?","volume":"8","author":"Ebejer","year":"2016","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2019.111593_bib27","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1021\/jm501552x","article-title":"Trends and exceptions of physical properties on antibacterial activity for gram-positive and gram-negative pathogens","volume":"57","author":"Brown","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111593_bib28","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/605572","article-title":"Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"49","author":"Deresinski","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111593_bib29","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/AAC.00237-09","article-title":"In\u00a0vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus","volume":"53","author":"Singh","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111593_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mib.2013.01.012","article-title":"The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond","volume":"16","author":"Yoong","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2019.111593_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.micro.112408.134309","article-title":"Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus","volume":"64","author":"Otto","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2019.111593_bib32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/INF.0b013e3181ef2477","article-title":"Staphylococcus aureus pathogenesis secretion systems, adhesins, and invasins","volume":"29","author":"Bartlett","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ejmech.2019.111593_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004970","article-title":"Staphylococcus aureus leukocidin A\/B (LukAB) kills human monocytes via host NLRP3 and ASC when extracellular, but not intracellular","volume":"11","author":"Melehani","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.111593_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chom.2013.09.005","article-title":"Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection","volume":"14","author":"Reyes-Robles","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2019.111593_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/cmi.12527","article-title":"Intracellular replication of Staphylococcus aureus in mature phagolysosomes in macrophages precedes host cell death, and bacterial escape and dissemination","volume":"18","author":"Flannagan","year":"2016","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejmech.2019.111593_bib36","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1007\/BF01644037","article-title":"Activity of intracellular antibiotics","volume":"19","author":"Vanderauwera","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.ejmech.2019.111593_bib37","first-page":"570","article-title":"Intracellular activity, potential clinical uses of antibiotics","volume":"64","author":"Rakita","year":"1998","journal-title":"ASM News"},{"key":"10.1016\/j.ejmech.2019.111593_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10156-007-0521-Z","article-title":"The bactericidal effects of anti-MRSA agents with rifampicin and sulfamethoxazole-trimethoprim against intracellular phagocytized MRSA","volume":"13","author":"Yamaoka","year":"2007","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.ejmech.2019.111593_bib39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0012-3692(15)33412-7","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ejmech.2019.111593_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijantimicag.2013.07.006","article-title":"Synthetic organic compounds with potential for bacterial biofilm inhibition, a path for the identification of compounds interfering with quorum sensing","volume":"42","author":"Pimenta","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.111593_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molcel.2011.04.003","article-title":"A\u00a0strategy for antagonizing quorum sensing","volume":"42","author":"Chen","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.111593_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijantimicag.2008.02.009","article-title":"Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus","volume":"32","author":"Kwon","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.111593_bib43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2011.06281.x","article-title":"New approaches for treating staphylococcal biofilm infections","volume":"1241","author":"Kiedrowski","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2019.111593_bib44","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ijantimicag.2010.11.004","article-title":"Catheter-related bloodstream infections: catheter management according to pathogen","volume":"36","author":"Leonidou","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.111593_bib45","first-page":"32","article-title":"Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion","volume":"135","author":"Francois","year":"2000","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.ejmech.2019.111593_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S0074-02762011000100008","article-title":"High vancomycin resistance among biofilms produced by Staphylococcus species isolated from central venous catheters","volume":"106","author":"Antunes","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2019.111593_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4248\/IJOS11026","article-title":"The clinical impact of bacterial biofilms","volume":"3","author":"Hoiby","year":"2011","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.ejmech.2019.111593_bib48","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1039\/C8RA10525A","article-title":"tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity","volume":"9","author":"Kotb","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.111593_bib49","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/AAC.37.12.2522","article-title":"Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm","volume":"37","author":"Dunne","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111593_bib50","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, M7-A9","author":"Clinical","year":"2012"},{"key":"10.1016\/j.ejmech.2019.111593_bib51","article-title":"Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent","volume":"5","author":"Thangamani","year":"2015","journal-title":"Sci. Rep. UK"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:00:50Z","timestamp":1759327250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419307275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":51,"alternative-id":["S0223523419307275"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111593","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111593"}}